Chromadex Corp (NASDAQ:CDXC)
| 1.55 BATS BZX Real-Time Price As of 10:12am ET |  -0.05 / -3.13%Today’s Change | 1.15 Today|||52-Week Range 2.76 | -7.74% Year-to-Date |
Latest CDXC News | Press Releases
No recent news for Chromadex Corp.
Today’s Trading
| Previous close | 1.60 |
| Today’s open | 1.59 |
| Day’s range | 1.53 - 1.59 |
| Volume | 2,873 |
| Average volume (3 months) | 189,243 |
| Market cap | $123.5M |
Data as of 10:12am ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | +41.26% |
| Earnings growth (this year) | +43.32% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +6.82% |
| P/E ratio | NM |
| Price/Sales | 1.63 |
| Price/Book | 4.29 |
Competitors
| ---- | ||
| CDTXCidara Therapeutics ... | +0.11 | +8.80% |
| ATOSAtossa Therapeutics ... | +0.03 | +4.41% |
| CATXPerspective Therapeu... | -0.01 | -0.88% |
Data as of 10:22am ET, 03/30/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $72.1M |
| Annual profit (last year) | -$16.5M |
| Net profit margin | -22.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
